The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients

By A. Yang, Jian-Ping Liu, Wen-qiang Tao, Hui-ming Li. International Immunopharmacology, 2020

998 citations recorded by the source corpus.

Highlights • The COVID-19 emerged in Wuhan City and rapidly spread throughout China.• NLR exhibited the largest area under the curve, with the highest specificity and sensitivity.• Elevated NLR can be considered independent biomarkers for indicating poor clinical outcomes.

Subfields: Infectious Diseases, Obstetrics and Gynecology, Oncology

View Paper: https://www.semanticscholar.org/paper/b08d525d3108aa79e9ef953d81f6d6d9dc8cb452

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Tomasi
2. G. Ponti
3. C. Ruini
4. T. Ozben
5. M. Maccaferri

Citations in the corpus

• Biomarkers associated with COVID-19 disease progression (2020, result): “57) as an independent factor for poor COVID-19 clinical outcome [44], which was confirmed by a meta-analysis which reported that NLR values were significantly increased in severe COVID-19 patients [45].”